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The incidence of laryngeal histoplasmosis is low when 
compared to the total number of cases. Less than 100 cases of 
laryngeal histoplasmosis have been described in the medical 
literature. Isolated laryngeal involvement may lead to the 
misdiagnosis and mistreatment of tuberculosis or laryngeal 
cancer, according to some reports. The development of 
hoarseness in a patient with histoplasmosis or a laryngeal 
mass leading to hoarseness, might be suggestive of laryngeal 
histoplasmosis. When histoplasmosis is included among the 
differential diagnoses of a laryngeal lesion, the biopsy should 
be limited to a small tissue fragment, enough to perform 
histological tests. The laboratory technicians must be warned 
about the possibility of histoplasmosis, because special dyes 
have to be used to confirm this diagnosis. 
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INTRODUCTION
Recently, granulomatous diseases, caused by in-
fectious agents, have occurred more frequently than they 
were described before. Such occurrence may be explained 
by the increase in the number of patients with immune 
diseases, or patients who are submitted to treatment by 
immunosuppressive agents, and the growing number of 
elderly patients with immunosuppression. 
Laryngeal histoplasmosis is a rare condition that may 
mimic tuberculosis or even laryngeal cancer, and must be 
considered in the differential diagnosis of a patient with 
hoarseness, diagnosed with histoplasmosis and, moreover, 
in the differential diagnosis of tumors in the vocal folds, 
causing hoarseness. Biopsy must be limited, removing 
the least possible amount of tissue and the pathologist 
must be told of the possibility of using special dyes for 
diagnostic confirmation.
Amphotericin B is the drug of choice for the tre-




Histoplasmosis is a granulomatous disease of 
universal distribution, common, caused by a dimorphic 
intracellular fungus, Histoplasma capsulatum. According 
to Goodwin Jr. et al1, it was Monbreun, in 1934, who first 
saw that the histoplasma had two ways of growing, in 
room temperature (as a filamentous fungus) and in body 
temperature (like yeasts). The fungus invades the reticular-
endothelial system.
There are endemic areas, such as in the valleys of 
rivers Ohio and Mississipi2, in the USA, where about 80-
90% of the population is affected.3
This fungus can be found in caves, hen houses or 
even on the ground contaminated by bats’ or birds’ feces.3 
After the organisms are inhaled, there is a primary infec-
tion. The factors that impact its progression are: 
1. The number of organisms inhaled;
2. The patient’s age (less than 6 years or elderly 
citizens);
3. Immune status (immunosuppression);
4. Nutritional status (malnutrition).
 
Furcolow classifies histoplasmosis in3:
1) Acute pulmonary histoplasmosis
1.1.assymptomatic 
1.2.symptomatic: mild, moderate and severe;
 
2) Chronic pulmonary histoplasmosis;
3)  Acute spread histoplasmosis;
 
4)  Cronic spread histoplasmosis: 







There are two types of primary infection according 
to the number of organisms inhaled: 1. Infection with a 
moderate number of organisms, and 2. Infection with a 
massive number of organisms inhaled, usually in bat caves 
or in hen houses. In the former, there is asymptomatic 
or mild respiratory infection with one or few primary 
pulmonary sites. In the latter, the picture is much worse, 
there are multiple and simultaneous primary sites, if the 
disease is not treated then, it progresses to cavitation or 
some type of spread disease. 
With the primary infection there is a fast and transi-
tory systemic spread. For most patients the disease is limi-
ted to this point. For most immunocompetent patients, it is 
asymptomatic or is similar to a cold in its symptoms.4
In acute spread cases, usually in children below one 
year of age or in severely immunosuppressed patients, 
there is fever, weight loss, liver and spleen enlargement 
and pancytopenia, and the patient may develop shock, 
respiratory failure and disseminated intra-vascular coagula-
tion (DIVC). In the cases when the infection extends - the 
acute spread, there may also be adrenalitis, endocarditis, 
meningitis, and ulcerations in the oral mucosa and in the 
intestine. In the chronic forms there is fever, weight loss, 
asthenia, liver and spleen enlargement and oral mucosa 
lesions are very common. In the acute forms, ulcerations 
were much less frequent.1
Chronic pulmonary histoplasmosis is very much 
similar to tuberculosis, with slow progressive fever, weight 
loss and respiratory symptoms with chest x-rays showing 
areas of excessive cavitation and fibrosis.1 It must espe-
cially be considered in patients who do not respond to 
tuberculosis treatment, in whom the tuberculosis agent 
was not identified.5 Differently from the patients with the 
spread form of the disease, these here do not have the 
involvement of other organs (muco-cutaneous, meningitis, 
pericarditis, adrenal failure forms of the disease). Staloff et 
al.2 commented that the spread is very rare, as a clinically 
apparent infection, happening more frequently in immu-
nosuppressed and elderly patients, and more commonly 
in men. When the infection spreads, the histoplasma can 
invade almost any organ. The areas commonly involved 
are: bone marrow, lymph nodes, adrenal glands and 
gastrointestinal tract, just as the tongue and oral mucosa. 
Thus, laryngeal involvement occurs in the muco-
cutaneous form of the chronic spread disease. Common 
initial manifestations are: pain to swallow, hoarseness, 
gingival ulceration and dysphagia.6 It is also common for 
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these patients to complain of weight loss, malaise and 
fatigue.5 Hepatoesplenomegaly can occur in 30-50% of the 
cases, as well as skin ulcerations. Mucosa ulcerations are 
the most frequent findings in these patients. They may last 
for long periods of time in any area of the larynx. Firm, 
painful ulcers, with elevated borders, involving the tongue, 
oral mucosa and the larynx are characteristic. Submucosa 
masses, with or without ulcerations may also appear - mi-
micking carcinomas. These ulcerations can involve the oral 
mucosa, the gum, the tongue, lips and pharynx.3
About 40-75% of adults and 18% of children with 
progressive spread histoplasmosis have oropharyngeal 
involvement.1,5 The clinical meaning of these oropharyn-
geal lesions is primarily diagnostic. In a study involving 
79 cases of histoplasmosis, Goodwin Jr. et al.1 reported 
that the mucosa ulceration distribution in the groups with 
acute, sub acute and spread chronic disease occurred in 
oropharyngeal and laryngeal involvement in 19% for the 
acute form, 31% for sub acute, and 66% of the cases with 
spread chronic diseases. They also reported that, as far 
as the site and frequency of such involvement is con-
cerned for the 58 oropharyngeal and laryngeal lesions; 
only 7 were located in the larynx in 29 cases of spread 
histoplasmosis.1
Local involvement of oral and laryngeal mucosa 
can represent the only sign of spread infection.7,8 During 
examination, the laryngeal mucosa can be pearl-white and 
edematous, or inflamed and ulcerated. The lesions can be 
similar to carcinoma or tuberculosis. Although most authors 
agree that the laryngeal manifestations indicate spread 
lesions, there are cases reported in which the laryngeal 
lesions were considered the primary ones.
For Smith, Utz9 only 15% of the patients had isolated 
laryngeal lesions, however 42% manifested the oro-laryn-
geal disease. 
According to Stallof et al.2, Hutchinson (1952) des-
cribed one case in which the disease happened specifically 
on the right vocal fold.
Wihters, Pappas10 described a similar case, but one 
that did not have signs of spread.
Bhalla et al.11, studying the causes of acquired non-
neoplastic laryngo-tracheal stenosis noticed that histoplas-
mosis was also part of the differential diagnosis, together 
with sarcoidosis, tuberculosis, osteoplastic tracheoplasty 
and Wegener’s granuloma. 
The lesions histopathologically classified by granu-
loma formation tend to form nodules by ulceration with 
elevated borders, while the lesions histopathologically 
characterized by histiocytic aggression (groups of parasited 
macrophages), associated with a more devastating disease, 
were superficial and more insignificant in appearance.1, 
12
Clinical diagnosis can be achieved with high levels 
of suspicion, especially in endemic areas, multiple calci-
fications seen in the chest x-ray, immunological tests, and 
the histological finding of the histoplasma in culture.5
One can collect a smear from the center of the 
ulcer for microscopy and culture. Special dyes usually 
show numerous macrophages with hifas, such as Gomori 
silver methenamine, Schiffi-Gridley periodic acid dye, with 
a superiority achieved with silver dyes (Grocott) when 
compared to PAS.5
The histoplasma is an intracellular organism that 
can be obtained from smears of ulcers in the oral cavity or 
from biopsies of oral and laryngeal tumors. During active 
infection, it is possible to see hifas in the macrophages, 
which are easily stained by PAS and Groccot (silver). It 
is also possible to see granulomas. Culture samples can 
come from sputum, bronchoalveolar secretions or from 
biopsy material. The organisms can be recovered in the 
Sabourauds’ medium.
Microscopically, histoplasmosis lesions can have tu-
berculoid granulomas with caseous necrosis areas, making 
it difficult to differentiate it from tuberculosis.
Immune tests are: skin test with histoplasmine (in 
endemic areas, because of its high positiveness, its use 
is reduced). Staloff et al.2 reported that over 85% of the 
samples from the population of endemic areas had positive 
skin tests. The complement fixation tests, which, contrary 
to the former, are the indirect and more valuable diagnostic 
procedure, become positive four weeks after the infection 
onset. After disease resolution, titles drop and usually 
disappear. Complement fixation tests are fundamental in 
order to establish a diagnosis, as well as to assess treatment 
response. In practice, titles of 1:4, 1:8 indicate the disease. 
Titles of 1:16 or a 4 fold or higher change in the titles are 
highly suggestive of infection. A negative complement 
fixation test does not rule out the spread form.3
The only diagnostic certainty is achieved by iso-
lating the microorganism.2 Biopsy shows granulomatous 
tissue, frequently necrosed, with an infiltrate of gigantic 
cells, lymphocytes, plasmocytic cells and a large number 
of macrophages. The organisms are not easily seen with 
the hematoxyline-eosin dye. However, with the Gomori 
silver methenamine, the macrophage appears with a va-
riable number of oval and round bodies, surrounded by 
a clear zone. These bodies represent an intracellular hifa 
of the H. capsulatum.3
Laryngeal histoplasmosis must be treated similarly to 
the other forms of the disease. Although benign, there can 
be dissemination with severe or even fatal manifestations. 
Treatment is carried out with endovenous anphotericin B, 
0.3-0.6 mg/kg of body weight per day, with a total dose 
of 2-4 mg. Mucosal lesions respond quickly (6-8 weeks), 
although there may be recurrencies.3
Goodwin Jr. et al.1 reported that a serum level of 
anphotericin B of 1.56 mg/mL for 10 weeks, with a total 
of 1g of intravenous medication, was usually enough for 
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cure, or, when the serum dosage is not available, one can 
use 50mg per day or three times a week, at a total dose 
of 2.0g. In children, 1mg/Kg/day for six weeks has been 
tried. Of their 84 cases treated with amphotericin B, 11 did 
not cure completely and required a new treatment. 
Fletcher, Prussin7 suggested that in immunocom-
petent patients with laryngeal histoplasmosis, one or two 
months of Ketoconazole could be administered, and if the-
re is improvement, treatment can remain for six months. 
Staloff et al.2 reported a case of histoplasmosis affec-
ting the larynx only, treated with 200 mg of Ketoconazole 
tid for 3 months. The patient underwent objective tests 14 
months after treatment, with good results.
Fernandez et al.13 reported successful treatment 
with itraconazole.
Negroni et al.14 treated 17 histoplasmosis patients 
with itraconazole, 100mg daily until clinical cure and, 
then, changed it to 50mg/day for six more months. All 
the infections were clinically cured, or improved greatly. 
12 cases had clinical cure, 4 extreme relief and 1 patient, 
who interrupted treatment after 2 months of itraconazole, 
died.
CLINICAL CASE
The patient came with hoarseness, progressive 
dysphagia, and having lost 10Kg in 2 months. He had had 
AIDS since 1996. At admission his blood work up showed 
2 CD4 + lymphocytes per mm3. Direct laryngoscopy was 
carried out and showed a white necrotic lesion spread 
throughout his larynx, edema and exophytic lesion in 
the upper right border of the epiglottis. We biopsied the 
lesions. We did not observe lesions on the skin. His adre-
nocortical, myelogram, CSF, ecocardiogram and skull CT 
scan were all normal. The result was histoplasmosis. The 
patient was submitted to a treatment with amphotericin 
B, with improvement and was discharged following a 
treatment with fluconazole.
Figure 1. Lesion on the right upper surface of the epiglottis - laryngeal 
histoplasmosis.
Figure 2. Soft palate and tongue without apparent lesions - laryngeal 
histoplasmosis.
DISCUSSION
Since 1952, when laryngeal histoplasmosis was ini-
tially described in the literature, less than 100 cases have 
been reported2. These figures are small if compared to the 
number of patients diagnosed with histoplasmosis every 
year. However, we must consider laryngeal involvement 
in the disease if a patient with histoplasmosis develops 
hoarseness.2
Macroscopically, histoplasmosis must be differentia-
ted from carcinoma, middle line granuloma, mucormyco-
sis, lymphoma, syphilis, tuberculosis and other head and 
neck granulomatous diseases. Microscopically, it may be 
mistaken with: 
1. paracoccidioidomycosis, with similar appearan-
ce;
2. tuberculosis in granulomatous histoplasmosis 
there are reports of central caseous necrosis - similar to 
tuberculosis;
3. squamous cells carcinoma - of atypical epithelial 
response. 
A tumor present in the vocal fold must also be 
included in the differential diagnosis of vocal fold tumors 
causing hoarseness, as well as in those cases in which the 
patient does not respond to tuberculosis treatment - in 
which the tuberculosis bacillus was not identified. Since 
usually the diagnosis requires a biopsy, when it is suspec-
ted in the preoperative, the biopsy must be limited, remove 
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the least possible amount of tissue in order to establish 
the diagnosis. The pathologist must also be aware of the 
need to use special dyes. It is recommended an accurate 
assessment in order to rule out spread disease. 
FINAL REMARKS
Differential diagnosis is of paramount importance, 
and one must consider carcinoma, mid-line granuloma, 
mucormycosis, lymphoma, syphilis, tuberculosis and other 
granulomatous diseases of the head and neck. Rajah5 trea-
ted, what he thought was tuberculosis in one of his patients 
for 10 months before the correct diagnosis, while Staloff 
et al.2 had their patient undergo two surgical procedures 
by another team with the diagnosis of vocal fold polyps, 
and later they suspected of papillomatosis. Gerber et al.15 
carried out chemotherapy and radiotherapy to treat cancer 
for 2 to 3 months, without improvement and achieved 
good results after instating proper treatment.
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